SToP Cancer SPORE: Career Enhancement Program
STOP Cancer SPORE:职业提升计划
基本信息
- 批准号:10705618
- 负责人:
- 金额:$ 8.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-16 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAdvocateAfrican AmericanAreaAwardBasic ScienceClinicClinicalClinical InvestigatorClinical SciencesCollaborationsCommunitiesComprehensive Cancer CenterDiagnosisDisabled PersonsDoctor of PhilosophyEarly DiagnosisFacultyFemaleFinancial SupportFosteringFundingFunding MechanismsGoalsGrantHistorically Black Colleges and UniversitiesImmunologyIndividualInstitutionJordanLaboratoriesLatino PopulationMalignant NeoplasmsMalignant neoplasm of pancreasMedicineMentorsMicrobiologyMinorityNorth CarolinaPancreasPatient CarePatientsPediatric Surgical ProceduresPeer ReviewPopulation SciencesPostdoctoral FellowPreventionProcessPublic HealthQualifyingResearchResearch PersonnelResourcesStudentsTeacher Professional DevelopmentTranslatingTranslational ResearchUnderrepresented MinorityUnderrepresented PopulationsUniversitiesVocational GuidanceWomanWorkWritinganticancer researchcareercareer developmentimproved outcomemembernext generationpancreatic cancer patientsprofessorprogramsrecruitstandard caresuccesstranslational pipelinetranslational progresstranslational scientist
项目摘要
CAREER ENHANCEMENT PROGRAM: ABSTRACT
The primary objective of the Career Enhancement Program (CEP) of the UNC Pancreas SPORE is to augment
the career development of a diverse group of faculty members who will focus on pancreatic cancer research.
This will be accomplished by 1) providing financial support to develop and enhance the research effort of these
faculty and 2) to provide both clinical and laboratory mentoring for investigators who are new to the field. We
intend to foster the research careers of translational investigators working in pancreatic cancer. The CEP will
select investigators for support from the entire spectrum of translational research in pancreatic cancer; including
those working in public health areas of prevention and early detection, diagnosis and other pertinent areas of
population science; basic science investigators working to translate their findings to patient care in the clinic and
translational/clinical investigators working to improve the outcome for patients with pancreatic cancer. We will
support highly qualified investigators who are new to the field of pancreatic cancer with a focus on early career
or mid-career investigators transitioning to work in this area.
The CEP is led by Jonathan Serody MD Associate Director for Translational Science at the Lineberger
Comprehensive Cancer Center and Elizabeth Thomas Professor of Medicine, Microbiology and Immunology.
The co-leaders are supported by the CEP Advisory Committee (CEPAC) that is chaired by the co-leaders and
includes Melissa Troester, PhD (Population Sciences), Anne Menkens, PhD (Administration), Antonio Baines
PhD (CEP Minority Advisor, NCCU), Albert Baldwin, PhD (Director DRP), and Andrea Hayes-Jordan (Pediatric
Surgery) and our patient advocates. Applicants will be selected from the highly qualified pool of investigators at
the University of North Carolina Chapel Hill and North Carolina Central University an Historic Black College and
University in Durham NC which has a strong scientific relationship with the Lineberger Comprehensive Cancer
Center and has a large African American and Latino population of students and postdoctoral fellows. Recruitment
of underrepresented minorities, disabled individuals, and women to pancreatic research will be emphasized and
will be the focus of Dr. Baines’s efforts on the CEPAC.
Financial support will be for an initial period of one year, that will be renewable if there has been appropriate
translational progress. We will collaborate with our partner institutions to strengthen multi-institutional
collaborations as the CEP matures.
职业增强计划:摘要
UNC胰腺孢子的职业增强计划(CEP)的主要目标是增强
将专注于胰腺癌研究的潜水员群体的职业发展。
这将通过1)提供财政支持来开发和增强这些研究的工作
教师和2)为新手的研究人员提供临床和实验室指导。我们
打算促进胰腺癌的翻译研究人员的研究事业。 CEP会
精选研究人员在整个翻译胰腺癌研究中的支持中提供支持;包括
那些从事预防和早期发现,诊断和其他相关领域的公共卫生领域的人
人口科学;基础科学调查人员致力于将其发现转化为诊所中的患者护理
转化/临床研究人员致力于改善胰腺癌患者的结果。我们将
支持高素质的调查人员,他们是胰腺癌领域的新手,重点是早期职业
或职业中期调查人员过渡到该领域的工作。
CEP由Lineberger的乔纳森血清塞底赛副总裁副总监
综合癌症中心和伊丽莎白·托马斯医学,微生物学和免疫学教授。
共同领导者得到了由联合领导者和
包括Melissa Troester博士(人口科学),Anne Menkens,Phd(管理),Antonio Baines
博士学位(NCCU CEP少数民族顾问),Albert Baldwin,博士(DRP)和Andrea Hayes-Jordan(儿科)
手术)和我们的患者拥护者。申请人将从高素质的调查员池中选中
北卡罗来纳大学教堂山和北卡罗来纳州中央大学一所历史悠久的黑人学院,
Durham NC的大学与Lineberger综合癌症有牢固的科学关系
中心,有大量的非裔美国人和拉丁裔学生和博士后研究员。招聘
将强调代表人数不足的少数族裔,残疾人和妇女进行胰腺研究
将是贝恩斯博士在CEPAC上的努力的重点。
财政支持将是一年的初期,如果有适当的话,这将是可续签的
翻译进度。我们将与我们的合作伙伴机构合作,以加强多机构
CEP成熟的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan S. Serody其他文献
<em>Characterization of a Cyclic Dinucleotide Metabolic Switch to Fuel Antitumor Immunity</em>
- DOI:
10.1182/blood-2022-169006 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Jeremy A. Meier;Katie E. Hurst;David L. Corcoran;Jessica E. Thaxton;Jonathan S. Serody - 通讯作者:
Jonathan S. Serody
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
- DOI:
10.1016/j.bbmt.2014.11.494 - 发表时间:
2015-02-01 - 期刊:
- 影响因子:
- 作者:
Thomas C. Shea;Christine M. Walko;Yunro Chung;Anastasia Ivanova;Kamakshi V. Rao;James Coghill;Stefanie Sarantopoulos;William A. Wood;Paul Armistead;Don A. Gabriel;Jonathan S. Serody - 通讯作者:
Jonathan S. Serody
Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma
- DOI:
10.1182/blood-2022-156660 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Timothy J. Voorhees;Anne W. Beaven;Christopher Dittus;George E Hucks;J. Kaitlin Morrison;Catherine Joyce Arago Cheng;Tammy Cavallo;Steven I. Park;Gianpietro Dotti;Jonathan S. Serody;Barbara Savoldo;Natalie S. Grover - 通讯作者:
Natalie S. Grover
Absence of ILC2 Recovery Post-Transplant Is Mediated By Epigenetic Conversion of ILC2 to Pro-Inflammatory ILC1-like Cells
- DOI:
10.1182/blood-2022-167045 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Sonia J. Laurie;Joseph P. Foster;Danny W. Bruce;Hemamalini Bommiasamy;Samantha G. Pattenden;Ian J. Davis;Jonathan S. Serody - 通讯作者:
Jonathan S. Serody
Cytotoxic Therapy Impairs the Stromal Niche Supporting ILC Development in the Bone Marrow
- DOI:
10.1182/blood-2022-165374 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Oleg Kolupaev;Danny W. Bruce;Sonia J. Laurie;Hemamalini Bommiasamy;Jonathan S. Serody - 通讯作者:
Jonathan S. Serody
Jonathan S. Serody的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan S. Serody', 18)}}的其他基金
UNC Immunotherapy Training Grant (IM-TAG)
北卡罗来纳大学免疫治疗培训补助金 (IM-TAG)
- 批准号:
10767617 - 财政年份:2023
- 资助金额:
$ 8.48万 - 项目类别:
SToP Cancer SPORE: Career Enhancement Program
STOP Cancer SPORE:职业提升计划
- 批准号:
10334089 - 财政年份:2022
- 资助金额:
$ 8.48万 - 项目类别:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
增强同种异体 HSCT 后的先天免疫重建。
- 批准号:
10297917 - 财政年份:2021
- 资助金额:
$ 8.48万 - 项目类别:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
增强同种异体 HSCT 后的先天免疫重建。
- 批准号:
10653130 - 财政年份:2021
- 资助金额:
$ 8.48万 - 项目类别:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
增强同种异体 HSCT 后的先天免疫重建。
- 批准号:
10470834 - 财政年份:2021
- 资助金额:
$ 8.48万 - 项目类别:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
ILC2 细胞治疗/预防 GVHD 的机制评估
- 批准号:
9403099 - 财政年份:2017
- 资助金额:
$ 8.48万 - 项目类别:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
ILC2 细胞治疗/预防 GVHD 的机制评估
- 批准号:
9918441 - 财政年份:2017
- 资助金额:
$ 8.48万 - 项目类别:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
ILC2 细胞治疗/预防 GVHD 的机制评估
- 批准号:
9528655 - 财政年份:2017
- 资助金额:
$ 8.48万 - 项目类别:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
皮肤 GVHD 中 Th1/Th17 巨噬细胞的相互作用
- 批准号:
9024463 - 财政年份:2012
- 资助金额:
$ 8.48万 - 项目类别:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
皮肤 GVHD 中 Th1/Th17 巨噬细胞的相互作用
- 批准号:
8626365 - 财政年份:2012
- 资助金额:
$ 8.48万 - 项目类别:
相似海外基金
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 8.48万 - 项目类别:
SToP Cancer SPORE: Career Enhancement Program
STOP Cancer SPORE:职业提升计划
- 批准号:
10334089 - 财政年份:2022
- 资助金额:
$ 8.48万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599557 - 财政年份:2022
- 资助金额:
$ 8.48万 - 项目类别:
2/2 CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP)
2/2 CSUF/UCI-CFCCC 癌症健康公平研究合作伙伴关系 (CHERP)
- 批准号:
10493213 - 财政年份:2021
- 资助金额:
$ 8.48万 - 项目类别:
1/2 CSUF/UCI-CFCCC Cancer Health Disparities Research Program (CHERP)
1/2 CSUF/UCI-CFCCC 癌症健康差异研究计划 (CHERP)
- 批准号:
10684039 - 财政年份:2021
- 资助金额:
$ 8.48万 - 项目类别: